Skip to main content

Articles

Page 1 of 20

  1. The Substance Abuse and Mental Health Services Administration’s (SAMHSA) Harm Reduction grant program expanded access to several harm reduction strategies to mitigate opioid overdose fatalities, including expa...

    Authors: Matthew R. Filteau, Brandn Green, Frances Kim and Ki-Ai McBride
    Citation: Harm Reduction Journal 2022 19:111
  2. Opioid-related overdose death is a public health epidemic in much of the USA, yet little is known about how people who use opioids (PWUO) experience overdose deaths in their social networks. We explore these e...

    Authors: Allison V. Schlosser and Lee D. Hoffer
    Citation: Harm Reduction Journal 2022 19:110
  3. Existing research in urban areas has documented a multitude of ways in which law enforcement may affect risks for bloodborne infectious disease acquisition among people who inject drugs (PWID), such as via syr...

    Authors: Sean T. Allen, Sarah Danforth, Suzanne M. Grieb, Jennifer L. Glick, Samantha J. Harris, Catherine Tomko and Susan G. Sherman
    Citation: Harm Reduction Journal 2022 19:109
  4. Injection drug use and needle sharing remains a public health concern due to the associated risk of HIV, HCV and skin and soft tissue infections. Studies have shown gendered differences in the risk environment...

    Authors: Katherine M. Rich, Julia Zubiago, Meghan Murphy, Rubeen Guardado and Alysse G. Wurcel
    Citation: Harm Reduction Journal 2022 19:108
  5. Access to sterile needles, syringes and methadone maintenance therapy (MMT) is critical to reduce the prevalence of bloodborne virus infections among people who inject drugs (PWID). We aimed to explore the exp...

    Authors: Win Lei Yee, Bridget Draper, Kyi Thar Myint, Win Min, Hla Htay, Daniel O’Keefe and Margaret Hellard
    Citation: Harm Reduction Journal 2022 19:107
  6. In 2016, the US state of North Carolina (NC) legalized syringe services programs (SSPs), providing limited immunity from misdemeanor syringe possession when law enforcement is presented documentation that syri...

    Authors: Brandon Morrissey, Tamera Hughes, Bayla Ostrach, Loftin Wilson, Reid Getty, Tonya L. Combs, Jesse Bennett and Jennifer J. Carroll
    Citation: Harm Reduction Journal 2022 19:106
  7. The impact of policing practices on the engagement of people who use drugs (PWUD) with harm reduction services is well evidenced. Although the police have traditionally taken an enforcement role in responding ...

    Authors: Danilo Falzon, Elizabeth V. Aston, Hannah Carver, Wendy Masterton, Bruce Wallace, Harry Sumnall, Fiona Measham, Emma Fletcher, Rosalind Gittins, Saket Priyadarshi and Tessa Parkes
    Citation: Harm Reduction Journal 2022 19:105
  8. Prescription opioids have been increasingly prescribed for chronic pain while the opioid-related death rates grow. Naloxone, an opioid antagonist, is increasingly recommended in these patients, yet there is li...

    Authors: Yinan Huang, Ning Lyu, Shrey Gohil, Shweta Bapat, E. James Essien and J. Douglas Thornton
    Citation: Harm Reduction Journal 2022 19:104
  9. Heroin pipe distribution may encourage people who use heroin (PWUH) to transition from injecting to smoking heroin, reducing harms associated with injection drug use. A syringe services program (SSP) in Seattl...

    Authors: Thomas Fitzpatrick, Vanessa M. McMahan, Noah D. Frank, Sara N. Glick, Lauren R. Violette, Shantel Davis and Shilo Jama
    Citation: Harm Reduction Journal 2022 19:103
  10. The COVID-19 pandemic has amplified the need for wide deployment of effective harm reduction strategies in preventing opioid overdose mortality. Placing naloxone in the hands of key responders, including law e...

    Authors: Elham Pourtaher, Emily R. Payne, Nicole Fera, Kirsten Rowe, Shu-Yin John Leung, Sharon Stancliff, Mark Hammer, Joshua Vinehout and Michael W. Dailey
    Citation: Harm Reduction Journal 2022 19:102
  11. Australian harm reduction services are provided via a mix of modalities, including fixed-site needle and syringe programmes (NSP) and syringe-dispensing machines (SDMs). SDMs are cost-effective and provide 24-...

    Authors: Daniel O’Keefe, Michael Livingston, Reece D. Cossar, Phoebe Kerr, David Jacka and Paul Dietze
    Citation: Harm Reduction Journal 2022 19:101
  12. Vaccine-hesitant persons who inject drugs are at increased risk for several vaccine-preventable diseases. However, vaccination rates among this population remain low. While syringe services programs (SSPs) are...

    Authors: Monique Carry, Danae Bixler, Mark K. Weng, Mona Doshani, Emma Roberts and Martha P. Montgomery
    Citation: Harm Reduction Journal 2022 19:100
  13. People who use drugs in Scotland are currently experiencing disproportionately high rates of drug-related deaths. Drug consumption rooms (DCRs) are harm reduction services that offer a safe, hygienic environme...

    Authors: Tessa Parkes, Tracey Price, Rebecca Foster, Kirsten M. A. Trayner, Harry R. Sumnall, Wulf Livingston, Andy Perkins, Beth Cairns, Josh Dumbrell and James Nicholls
    Citation: Harm Reduction Journal 2022 19:99
  14. In Scotland drug policy and consequently the progress of evidence-based treatment options has been struggling for many years. Political inaction is brought about by a complex chain of legal and operational obs...

    Authors: Catriona Matheson and Roy Robertson
    Citation: Harm Reduction Journal 2022 19:98
  15. Emergency departments (EDs) are important venues for the distribution of naloxone to patients at high risk of opioid overdose, but less is known about patient perceptions on naloxone or best practices for pati...

    Authors: Margaret Lowenstein, Hareena K. Sangha, Anthony Spadaro, Jeanmarie Perrone, M. Kit Delgado and Anish K. Agarwal
    Citation: Harm Reduction Journal 2022 19:97
  16. Increased opioid-related morbidity and mortality in racialized communities has highlighted the intersectional nature of the drug policy crisis. Given the racist evolution of the war on drugs and the harm reduc...

    Authors: Parnika Godkhindi, Lisa Nussey and Tim O’Shea
    Citation: Harm Reduction Journal 2022 19:96
  17. Substance use treatment and harm reduction services are essential components of comprehensive strategies for reducing the harms of drug use and overdose. However, these services have been historically siloed, ...

    Authors: Noa Krawczyk, Sean T. Allen, Kristin E. Schneider, Keisha Solomon, Hridika Shah, Miles Morris, Samantha J. Harris, Susan G. Sherman and Brendan Saloner
    Citation: Harm Reduction Journal 2022 19:95
  18. Resilience is a commonly used construct in substance use and mental health research. Yet it is often narrowly defined by only its internal qualities (e.g., adaptability, hardiness) and overlooks its external q...

    Authors: Catherine Tomko, Danielle Friedman Nestadt, Noelle P. Weicker, Katherine Rudzinski, Carol Underwood, Michelle R. Kaufman and Susan G. Sherman
    Citation: Harm Reduction Journal 2022 19:94
  19. Incarcerated people are at an increased risk of contracting HIV and transmitting it to the community post-release. In Iran, HIV epidemics inside prisons were first detected in the early 1990s. We assessed the ...

    Authors: Armita Shahesmaeili, Mohammad Karamouzian, Fatemeh Tavakoli, Mostafa Shokoohi, Ali Mirzazadeh, Samira Hosseini-Hooshyar, Saber Amirzadeh Googhari, Nima Ghalekhani, Razieh Khajehkazemi, Zahra Abdolahinia, Noushin Fahimfar, AliAkbar Haghdoost and Hamid Sharifi
    Citation: Harm Reduction Journal 2022 19:93
  20. Authors: Jean Olivier Twahirwa Rwema, Vianney Nizeyimana, Neia M. Prata, Nneoma E. Okonkwo, Amelia A. Mazzei, Sulemani Muhirwa, Athanase Rukundo, Lisa Lucas, Audace Niyigena, Jean Damascene Makuza, Chris Beyrer, Stefan D. Baral and Aflodis Kagaba
    Citation: Harm Reduction Journal 2022 19:91

    The original article was published in Harm Reduction Journal 2021 18:130

  21. People who both smoke cigarettes and vape are often considered as a homogenous group even though multiple subgroups may exist. We examined biomarkers of exposure (BOE) and biomarkers of potential harm (BOPH) t...

    Authors: Pavel N. Lizhnyak, Brendan Noggle, Lai Wei, Jeffery Edmiston, Elizabeth Becker, Ryan A. Black and Mohamadi Sarkar
    Citation: Harm Reduction Journal 2022 19:90
  22. Opioid agonist treatment (OAT) is the primary intervention for opioid use disorder (OUD) in Canada and the USA. Yet, a number of barriers contribute to sub-optimal treatment uptake and retention, including dai...

    Authors: Cayley Russell, Shannon Lange, Fiona Kouyoumdjian, Amanda Butler and Farihah Ali
    Citation: Harm Reduction Journal 2022 19:89
  23. Australia has had a framework for legal medicinal cannabis since 2016, yet prior online surveys in 2016 and 2018 indicated that most consumers continued to use illicit medical cannabis products. Regulatory dat...

    Authors: Nicholas Lintzeris, Llewellyn Mills, Sarah V. Abelev, Anastasia Suraev, Jonathon C. Arnold and Iain S. McGregor
    Citation: Harm Reduction Journal 2022 19:88
  24. Supervised injection facilities (SIFs) provide spaces where persons who inject drugs (PWID) can inject under medical supervision and access harm reduction services. Though SIFs are not currently sanctioned in ...

    Authors: Eliana Duncan, Sarah Shufelt, Meredith Barranco and Tomoko Udo
    Citation: Harm Reduction Journal 2022 19:87
  25. Police action can increase risky substance use patterns by people who use drugs (PWUD), but it is not known how increased police presence affects utilization of low-barrier substance use disorder bridge clinic...

    Authors: Karrin Weisenthal, Simeon D. Kimmel, Jessica Kehoe, Marc R. Larochelle, Alexander Y. Walley and Jessica L. Taylor
    Citation: Harm Reduction Journal 2022 19:86
  26. Authors: Alice Zhang, Joseph A. Balles, Jennifer E. Nyland, Thao H. Nguyen, Veronica M. White and Aleksandra E. Zgierska
    Citation: Harm Reduction Journal 2022 19:85

    The original article was published in Harm Reduction Journal 2022 19:67

  27. The meaningful inclusion of young people who use or have used drugs is a fundamental aspect of harm reduction, including in program design, research, service provision, and advocacy efforts. However, there are...

    Authors: M-J Stowe, Orsi Feher, Beatrix Vas, Sangeet Kayastha and Alissa Greer
    Citation: Harm Reduction Journal 2022 19:83
  28. Internationally, strategies focusing on reducing alcohol-related harms in homeless populations with severe alcohol use disorder (AUD) continue to gain acceptance, especially when conventional modalities focuse...

    Authors: Shannon M. Smith-Bernardin, Leslie W. Suen, Jill Barr-Walker, Isabel Arrellano Cuervo and Margaret A. Handley
    Citation: Harm Reduction Journal 2022 19:82
  29. The impact of public health policies during the COVID-19 pandemic on people who inject drugs (PWID) has varied across regions. In other countries, recent research has shown that PWID access to harm reduction s...

    Authors: Kinna Thakarar, Michael Kohut, Rebecca Hutchinson, Rebecca Bell, Hannah E. Loeb, Debra Burris and Kathleen M. Fairfield
    Citation: Harm Reduction Journal 2022 19:80
  30. US overdose deaths have reached a record high. Syringe services programs (SSPs) play a critical role in addressing this crisis by providing multiple services to people who use drugs (PWUD) that help prevent ov...

    Authors: Madeline C. Frost, Elizabeth J. Austin, Maria A. Corcorran, Elsa S. Briggs, Czarina N. Behrends, Alexa M. Juarez, Noah D. Frank, Elise Healy, Stephanie M. Prohaska, Paul A. LaKosky, Shashi N. Kapadia, David C. Perlman, Bruce R. Schackman, Don C. Des Jarlais, Emily C. Williams and Sara N. Glick
    Citation: Harm Reduction Journal 2022 19:79
  31. Syringe service programs (SSPs) provide essential harm reduction and prevention services for people who inject drugs in the USA, where SSP coverage is expanding. During the COVID-19 pandemic, US SSPs underwent...

    Authors: Andrea Wang, Raagini Jawa, Sarah Mackin, Liz Whynott, Connor Buchholz, Ellen Childs and Angela R. Bazzi
    Citation: Harm Reduction Journal 2022 19:78
  32. The dual COVID-19 and overdose emergencies amplified strain on healthcare systems tasked with responding to both. One downstream consequence of the pandemic in the USA and Canada was a surge in drug overdoses ...

    Authors: Karen McCrae, Stephanie Glegg, Marie-Éve Goyer, Bernard Le Foll, Rupi Brar, Christy Sutherland and Nadia Fairbairn
    Citation: Harm Reduction Journal 2022 19:77
  33. Illicit fentanyl has contributed to a drastic increase in overdose drug deaths. While fentanyl has subsumed the drug supply in the Northeastern and Midwestern USA, it has more recently reached the Western USA....

    Authors: Sarah S. Shin, Kate LaForge, Erin Stack, Justine Pope, Gillian Leichtling, Jessica E. Larsen, Judith M. Leahy, Andrew Seaman, Daniel Hoover, Laura Chisholm, Christopher Blazes, Robin Baker, Mikaela Byers, Katie Branson and P. Todd Korthuis
    Citation: Harm Reduction Journal 2022 19:76
  34. Syringe services programs (SSPs) hold promise for providing buprenorphine treatment access to people with opioid use disorder (OUD) who are reluctant to seek care elsewhere. In 2017, the New York City Departme...

    Authors: Andrea Jakubowski, Caroline Rath, Alex Harocopos, Monique Wright, Alice Welch, Jessica Kattan, Czarina Navos Behrends, Teresa Lopez-Castro and Aaron D. Fox
    Citation: Harm Reduction Journal 2022 19:75
  35. Delivery of effective health care is hampered by stigma, the social processes that attach negative judgement and response to some attributes, conditions, practices and identities. Experiencing or anticipating ...

    Authors: Carla Treloar, Elena Cama, Kari Lancaster, Loren Brener, Timothy R. Broady, Aaron Cogle and Darryl O’Donnell
    Citation: Harm Reduction Journal 2022 19:74
  36. Safe consumption sites (SCSs) serve diverse populations of people who use drugs (PWUD) and public health objectives. SCS implementation began in the 1980s, and today, there are at least 200 known SCSs operatin...

    Authors: Grace H. Yoon, Timothy W. Levengood, Melissa J. Davoust, Shannon N. Ogden, Alex H. Kral, Sean R. Cahill and Angela R. Bazzi
    Citation: Harm Reduction Journal 2022 19:73
  37. Fatal drug overdoses in the USA hit historical records during the COVID-19 pandemic. Throughout the pandemic, people who used drugs had greater odds of contracting COVID-19, increased drug use due to COVID-rel...

    Authors: Fiona N. Conway, Jake Samora, Katlyn Brinkley, Haelim Jeong, Nina Clinton and Kasey R. Claborn
    Citation: Harm Reduction Journal 2022 19:72
  38. Take-Home Naloxone (THN) is a core intervention aimed at addressing the toxic illicit opioid drug supply crisis. Although THN programs are available in all provinces and territories throughout Canada, there ar...

    Authors: Max Ferguson, Andrea Medley, Katherine Rittenbach, Thomas D. Brothers, Carol Strike, Justin Ng, Pamela Leece, Tara Elton-Marshall, Farihah Ali, Diane L. Lorenzetti and Jane A. Buxton
    Citation: Harm Reduction Journal 2022 19:71
  39. The opioid epidemic is a progressively worsening public health crisis that continues to impact healthcare system strategies such as overdose reversal and destigmatization. Even among healthcare professionals, ...

    Authors: Reena K. Sandhu, Michael V. Heller, Jack Buckanavage, Benjamin Haslund-Gourley, Joshua Leckron, Brady Kupersmith, Nathaniel C. Goss, Kyle Samson and Annette B. Gadegbeku
    Citation: Harm Reduction Journal 2022 19:70
  40. Buprenorphine and naloxone are first-line medications for people who use opioids (PWUO). Buprenorphine can reduce opioid use and cravings, help withdrawal symptoms, and reduce risk of opioid overdose. Naloxone...

    Authors: David Dadiomov, Maria Bolshakova, Melania Mikhaeilyan and Rebecca Trotzky-Sirr
    Citation: Harm Reduction Journal 2022 19:69
  41. Women who use heroin and other drugs (WWUD) are a key population with elevated risk of physical and sexual violence perpetrated by intimate partners and non-partners. While housing instability has been shown t...

    Authors: Claire Silberg, Samuel Likindikoki, Jessie Mbwambo, Kristin Mmari and Haneefa T. Saleem
    Citation: Harm Reduction Journal 2022 19:68
  42. Individuals with substance use disorder often encounter law enforcement due to drug use-related criminal activity. Traditional policing approaches may not be effective for reducing recidivism and improving out...

    Authors: Alice Zhang, Joseph A. Balles, Jennifer E. Nyland, Thao H. Nguyen, Veronica M. White and Aleksandra E. Zgierska
    Citation: Harm Reduction Journal 2022 19:67

    The Correction to this article has been published in Harm Reduction Journal 2022 19:85

  43. The aim of this study was to critically analyse information concerning the relationship between alcohol and food consumption provided via alcohol industry (AI) funded and non-AI-funded health-oriented websites...

    Authors: Anna Ramsbottom, May C. I. van Schalkwyk, Lauren Carters-White, Yasmine Benylles and Mark Petticrew
    Citation: Harm Reduction Journal 2022 19:66
  44. As the opioid overdose crisis persists and take-home naloxone (THN) programmes expand, it is important that the intervention is targeted towards those most likely to use it. We examined THN program participant...

    Authors: Desiree Eide, Philipp Lobmaier and Thomas Clausen
    Citation: Harm Reduction Journal 2022 19:65
  45. Traditional heroin-assisted treatment in Switzerland consists of oral and injectable diacetylmorphine (pharmaceutical heroin) administration. To date, no suitable treatment option is available for patients who...

    Authors: Maximilian Meyer, Jean N. Westenberg, Johannes Strasser, Kenneth M. Dürsteler, Undine E. Lang, Michael Krausz and Marc Vogel
    Citation: Harm Reduction Journal 2022 19:63